Skip to content

Efficacy of paracervical block versus pentazocine as analgesia during manual vacuum aspiration at FCTA Hospitals – a randomised control trial.

Efficacy of paracervical block versus pentazocine as analgesia during manual vacuum aspiration at the FCTA Hospitals – a randomised control trial.

Status
Recruiting
Phases
Early Phase 1
Study type
Interventional
Source
PACTR
Registry ID
PACTR202607549983165
Enrollment
100
Registered
2026-07-07
Start date
2026-02-24
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Missed miscarriage, incomplete miscarriage

Interventions

Intramuscular pentazocine group

Sponsors

Daula Hashim
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: Women with a first-trimester incomplete abortion (spontaneous or induced) who had the pregnancy confirmed clinically and by ultrasound and who gave consent to the study. Confirmed pregnancy of a gestational age of up to 12 weeks or less at the time of the abortion, and/or uterine size less than 12weeks gestation on clinical examination. Hemodynamically stable women at presentation

Exclusion criteria

Exclusion criteria: Women with the following conditions were excluded from the study: Active infection (such as septic abortion) allergies to lidocaine and pentazocine mentally unstable women, such as those with psychiatric disorders severe illnesses or comorbidities uterine perforation, huge uterine fibroids severe anaemia.

Design outcomes

Primary

MeasureTime frame
The primary outcome measure of this study will be the intensity of pain experienced by participants during and after manual vacuum aspiration, assessed using the Visual Analogue Scale (VAS).

Secondary

MeasureTime frame
1. Need for rescue analgesia, defined as administration of additional analgesia due to inadequate pain control (VAS =7) during or immediately after the procedure. 2. Occurrence of adverse drug reactions, including but not limited to nausea, vomiting, dizziness, sedation, allergic reactions, or local anaesthetic toxicity. 3. Procedure-related complications, such as excessive bleeding, vasovagal reactions, or uterine perforation.

Countries

Nigeria

Contacts

Public ContactSaudah Sambo

ASSISTANT RESEARCHER

saudah82@yahoo.com+2348139976687

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Aug 10, 2026